THERAVANCE BIOPHARMA, INC. (TBPH) Total assets 2016–2025
THERAVANCE BIOPHARMA, INC. (TBPH) total assets at each fiscal year-end, per SEC filings.
$485.6MFY2025 · since FY2016: $639.3M → $485.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $485.6M | +37.1% |
| FY2024 | $354.2M | -7.3% |
| FY2023 | $382.0M | -37.1% |
| FY2022 | $607.4M | +62.1% |
| FY2021 | $374.8M | -20.1% |
| FY2020 | $469.1M | +14.7% |
| FY2019 | $408.8M | -27.0% |
| FY2018 | $560.2M | +26.9% |
| FY2017 | $441.4M | -31.0% |
| FY2016 | $639.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice